Beihai Gofar Chuanshan Biological Co., Ltd.

Equities

600538

CNE000001DD2

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
4.63 CNY -0.22% Intraday chart for Beihai Gofar Chuanshan Biological Co., Ltd. -6.28% -0.22%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Beihai Gofar Chuanshan Biological Gets Patent for Extraction Module MT
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Beihai Gofar Chuanshan Biological Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Beihai Gofar Chuanshan Biological Co., Ltd. announced that it has received CNY 12.427005 million in funding CI
Eastern Pioneer Driving School : China stocks edge higher on energy, transport gains RE
Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
Beihai Gofar Marine Biological Industry Co., Ltd. announced a financing transaction CI
Beihai Gofar Marine Biological Industry Co., Ltd. completed the acquisition of 99.98% stake in Guangzhou Koalson Biotechnology Co.,Ltd. from a group of sellers. CI
Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
Beihai Gofar Marine Biological Industry Co., Ltd. Predicts Performance Profit in 2019 CI
Beihai Gofar Marine Biological Industry Co., Ltd. agreed to acquire 99.98% stake in Guangzhou Koalson Biotechnology Co.,Ltd. from a group of sellers for approximately CNY 360 million. CI
Beihai Gofar Chuanshan Biological Co., Ltd. announced that it expects to receive CNY 100 million in funding CI
Beihai Gofar Marine Biological Industry Co., Ltd. cancelled the acquisition of 30% stake in Beijing Xiangya Medical Technology Co., Ltd. from Beijing Physician Joint Technology Development Center (Limited Partnership), Wang Haolin and Xue Fan. CI
Beihai Gofar Marine Biological Industry Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019 CI
Chart Beihai Gofar Chuanshan Biological Co., Ltd.
More charts
Beihai Gofar Chuanshan Biological Co Ltd, formerly Beihai Gofar Marine Biological Industry Co Ltd, is a China-based company mainly engaged in the production and sales of pharmaceutical products and pesticide products. The Company is mainly engaged in the Pharmaceutical Distribution segment, the Pharmaceutical Manufacturing segment, the Deoxyribonucleic Acid Identification and Service segment, and the Other segment. The Company is mainly engaged in pharmaceutical manufacturing and pharmaceutical distribution industries, molecular medical imaging centers, tumor radiotherapy centers, and tumor telemedicine technical services, molecular diagnostics and judicial identification technical services. The Company mainly sells its products in the domestic market.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 600538 Stock
  4. News Beihai Gofar Chuanshan Biological Co., Ltd.
  5. Beihai Gofar Chuanshan Biological Gets Patent for Extraction Module